Role of cytochrome P450c17 in polycystic ovary syndrome

Molecular and Cellular Endocrinology

Volumn 145, Issue 1-2, 1998, Pages 111-121

  Qin, Ke nan ^a   Rosenfield, Robert L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Dysregulation of steroidogenesis; Insulin like growth factors; P450c17; Polycystic ovary syndrome

Indexed keywords

CYTOCHROME P450 ISOENZYME; SOMATOMEDIN;

ANDROGEN SYNTHESIS; CONFERENCE PAPER; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEROIDOGENESIS;

FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; INSULIN-LIKE GROWTH FACTOR I; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0032566950     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00177-4     Document Type: Conference Paper

References (116)

1. Abad L., Parrilla J., Marcos J., Gimeno F., Lopez Bernal A. Male pseudohermaphroditism with 17 alpha-hyderoxylase deficiency; a case report. Br. J. Obstet. Gynaecol. 87:1980;1162-1165.
2. Apter D., Bützow T., Laughlin G., Yen S. Accelerated 24 h luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 79:1994;119-125.
3. 5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J. Biol. Chem. 273:1998;3158-3165.
4. Axelrod L., Goldzieher J. The polycystic ovary III steroid biosynthesis in normal and polycystic ovarian tissue. J. Clin. Endocrinol. 22:1962;431-440.
5. Bakke M., Lund J. Mutually exclusive interactions of two nuclear orphan receptors determine activity of a cyclic adenosine 3′, 5′-monophosphate-responsive sequence in the bovine CYP17 gene. Mol. Endocrinol. 9:1995;327-339.
6. Barbieri R., Makris A., Randall R., Daniels G., Kistner R., Ryan K. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 62:1986;904-910.
7. Barnes R.B., Rosenfield R.L., Burstein S., Ehrmann D.A. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. New Engl. J. Med. 320:1989;559-565.
8. Bergh C., Carlsson B., Olssonn J.-H., Selleskogn U., Hillensjon T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil. Steril. 59:1993;323-331.
9. Biason-Lauber A., Leiberman E., Zachmann M. A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of isolated 17,20-lyase deficiency. J. Clin. Endocrinol. Metab. 82:1997;3807-3812.
10. Borroni R., Liu Z., Simpson E., Hinshelwood M. A putative binding site for Sp1 is involved in transcriptional regulation of CYP17 gene expression in bovine ovary. Endocrinology. 138:1997;2011-2020.
11. Brentano S., Picado-Leonard J., Mellon S., Moore C., Miller W. Tissue-specific; cAMP-induced; and phorbol ester repressed expression from the human P450c17 promoter in mouse cells. Mol. Endocrinol. 4:1990;1972-1979.
12. Burghen G., Givens J., Kitabchi A. Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50:1980;113-116.
13. Cara J.F., Rosenfield R.L. Insulin-like growth factor-I and insulin potentiate luteinizing hormone-induced androgen sythesis by rat ovarian theca-interstitial cells. Endocrinology. 123:1988;733-739.
14. Cara J.F., Fan J., Azzarello J., Rosenfield R.L. Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells. J. Clin. Invest. 86:1990;560-565.
15. Carey A.H., Chan K.L., Short F., White D., Williamson R., Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. 38:1993;653-658.
16. Carey A., Waterworth D., Patel K. et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP 17. Hum. Mol. Genet. 3:1994;1873-1876.
17. Carr B., McGee E., Sawetawan C., Clyne C., Rainey W. The effect of transforming growth factor-β on steroidogenesis and expression of key steroidogenic enzymes with a human ovarian theca-like tumor cell model. Am. J. Obstet. Gynecol. 174:1996;1109-1117.
18. Cascio C., Prasad V., Lin Y., Lieberman S., Papadopoulos V. Detection of P450c17-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc. Natl. Acad. Sci. USA. 95:1998;2862-2867.
19. Chang Y.T., Kulin H., Garbaldi L. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with flucocorticoid-treated nonsalt-wasting 3β-hydroxysteroid dehydrogenas deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 77:1993;1251-1257.
20. Chung B., Picado-Leonard J., Haniu M. et al. Cytochrome P450c17 (steroid 17-hydroxylase/17,20 lyase): Cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. USA. 84:1987;407-411.
21. Cloutier M., Fleury A., Courtemanche J., Ducharme L., Mason J., Lehoux J. Characterization of the adrenal cytochrome P450c17 in the hamster, a small animal model for the study of adrenal dehydroepiandrosterone biosythesis. DNA Cell. Biol. 16:1997;357-368.
22. Conte F., Grumbach M., Ito Y., Fisher C., Simpson E. A syndrome of female pseudohermaphroditism; hypergonadotropic hypogonadism; and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J. Clin. Endocrinol. Metab. 78:1994;1287-1292.
23. Cooper H., Spellacy W., Prem K., Cohen W. Hereditary factors in the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 100:1968;371-387.
24. D'Alberton A., Reschini E., Motta T., Catania A. Male pseudohermaphroditism due to 17-hydroxylase deficiency. J. Endocrinol. Invest. 12:1989;193-196.
25. Demeter-Arlotto M., Michael M., Kilgore M., Simpson E. 17α-hydroxylase gene expression in the bovine ovary: mechanisms regulating expression differ from those in adrenal cells. J. Steroid. Biochem. Mol. Biol. 59:1996;21-29.
26. Di Blasio A., Voutilainen R., Jaffe R., Miller W. Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 alpha-hydroxylase/17,20 lyase) in cultured human fetal adrenal cells. J. Clin. Endocrinol. Metab. 65:1987;170-175.
27. Dorfman R., Forchielli E., Gut M. Androgen biosynthesis and related studies. Rec. Prog. Horm. Res. 19:1963;251-273.
28. Dufau M., Winters C., Hattori M. Hormonal regulation of androgen production by the Leydig cell. J. Steroid. Biochem. 20:1984;161-173.
29. Dunaif A., Scott D., Finegood D., Quintana B., Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81:1996;3299-3306.
30. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18:1997;774-800.
31. Eckstein B., Greenbaum O., Cohen S. Kinetic studies on ovarian C-17,20-lyase activity: effect of luteinizing hormone surge. Endocrinology. 117:1985;2376-2382.
32. Ehrmann D.A., Rosenfield R.L., Barnes R.B., Brigell D.F., Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. New Engl. J. Med. 327:1992;157-162.
33. Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrin. Rev. 16:1995;322-353.
34. Fan Y., Sasi R., Lee C., Winter J., Waterman M., Lin C. Localization of the human CYP17 gene (cytochrome P450 17α to 10q24.3) by fluorescence in situ hybridization and simultaneous chromosome banding. Genomics. 14:1992;1110-1111.
35. Ferriman D., Purdie A. The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin. Endocrinol. 11:1979;291-300.
36. Fevold H., Lorence M., McCarthy J. et al. Rat P45017α from testis: characterization of a full-length cDNA encoding a unique steroid hydroxylase capable of catalyzing both Δ4- and Δ5-steroid-17,20-lyase reactions. Mol. Endocrinol. 3:1989;968-975.
37. Geller D., Auchus R., Mendonca B., Miller W. The genetic and functional basis of isolated 17,20-lyase deficiency. Nature Genet. 17:1997;201-205.
38. Gharani N., Waterworth D., Williamson R., Franks S. 5′ Polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. J. Clin. Endocrinol. Metab. 81:1996;4174.
39. Gilling-Smith C., Willis D.S., Beard R.W., Franks S. Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 79:1994;1158-1165.
40. Gilling-Smith C., Story H., Rogers V., Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. 47:1997;93-99.
41. Givens C., Zhang P., Bair S., Mellon S. Transcriptional regulation of rat cytochrome P450c17 expression in mouse Leydig MA-10 and adrenal Y1 cells: idemtification of a single protein that mediates both basal and cAMP-induced activities. DNA Cell. Biol. 13:1994;1087-1098.
42. Gonzalez F., Chang L.H.T., Lobo R. Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome. Fertil. Steril. 66:1996;354-361.
43. Gonzalez F. Adrenal involvement in polycystic ovary syndrome. Semin. Reprod. Endocrinol. 15:1997;159-168.
44. Hague W., Adams J., Reedwes S., Peto T., Dacobs H. Familial polycystic ovaries: a genetic disease. Clin. Endocrinol. 29:1988;593-605.
45. Hernandez E., Resnick C., Svoboda M., Van Wyck J., Payne D., Adashi E. Somatomedin-C/Insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology. 122:1988;1603-1612.
46. Hernandez E., Hurwitz A., Payne D., Kharmarjan A., Purchio A., Adashi E. Transforming growth factor-β1 inhibits ovarian androgen production: gene expression, cellular localization, mechanism(s) and site(s) of action. Endocrinology. 127:1990;2804-2811.
47. Holte J., Bergh T., Berne C. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 80:1995;2586-2593.
48. Ibañez L., Potau N., Virdis R. et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 76:1993;1599-1603.
49. Imai T., Globerman H., Gertner J., Kagawa N., Waterman M. Expression and purification of functional human 17α-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. J. Biol. Chem. 268:1993;19681-19689.
50. Jakubowicz D., Nestler J. 17α-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss. J. Clin. Endocrinol. Metab. 82:1997;556-560.
51. John M., John M., Boggaram V., Simpson E., Waterman M. Transcriptional regulation of steroid hydroxylase genes by ACTH. Proc. Natl. Acad. Sci. USA. 83:1986;4715-4719.
52. Kagawa N., Ogo A., Takahashi Y., Iwamatsu A., Waterman M. A cAMP-regulatory sequence (CRS1) of CYP17 is a cellular target for the homeodomain protein Pbx1. J. Biol. Chem. 269:1994;18716-18719.
53. Kase N., Forchielli E., Dorfman R. In vitro production of testosterone and androst-4-ene-3,17-dione in a human ovarian homogenate. Acta Endocrinol. 37:1961;19-23.
54. Katagiri M., Kagawa N., Waterman M. The role of cytochrome b5 in the biosynthesis of androgens by human P450c17. Arch. Biochem. Biophys. 317:1995;343-347.
55. Khan C., Flier J., Bar R., Archal J., Gorden P. The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. New Engl. J. Med. 294:1976;739-745.
56. Kiddy D.S., Hamilton-Fairley D., Bush A. et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. 36:1992;105-111.
57. Klinger B., Anin S., Silbergeld A., Eshet R., Laron Z. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin. Endocrinol. 48:1998;81-87.
58. Kristiansen S., Endoh A., Casson P., Nuster J., Hormsby P. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids. 62:1997;258-265.
59. Kuwada M., Takizawa N., Sone Y. The relation between two molecular species of P-450 in adult testis and 17α-hydroxylase and 17,20-lyase activities. Biochem. Biophys. Res. Commun. 218:1996;524-529.
60. L'Allemand D., Penhoat A., Lebrethon M.C. et al. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J. Clin. Endocrinol. Metab. 81(11):1996;3892-3897.
61. Labrie F., Simard J., Luu-The V. Structure, function and tissue-specific gene expression of 3b-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracine steroidogenic tissues. J. Steroid Biochem. Mol. Biol. 43:1992;805-826.
62. Legro R.S. The genetics of polycystic ovary syndrome. Am. J. Med. 98:1995;9S-16.
63. Lin D., Harikrishna J., Moore C., Jones K., Miller W. Missense mutation Ser106-Pro cause 17α-hydroxylase deficiency. J. Biol. Chem. 266:1991;15992-15998.
64. Lin D., Sugawara T., Strauss J.F. Jr. et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenisis. Science. 267:1995;1828-1831.
65. Lucky A.W., Rosenfield R.L., McGuire J., Rudy S., Helke J. Adrenal androgen hyperresponsiveness to ACTH in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J. Clin. Endocrinol. Metab. 62:1986;840-848.
66. Lund J., Ahlgren R., Wu D., Kagimoto M., Simpson E.R., Waterman M. Transcriptional regulation of the bovine CYP17 (P45017α) gene; identification of two cAMP regulatory regions lacking the consenses CRE. J. Biol. Chem. 265:1990;3304-3312.
67. Lund J., Bakke M., Mellgren G., Morohasi K., Doskeland S. Transcriptional regulation of the bovine CYP17 gene by cAMP. Steroids. 62:1997;43-45.
68. Magoffin D., Weitsman S. Differentiation of ovarian theca-interstitial cells in vitro: regulation of 17α-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulin-like growth factor-I. Endocrinology. 132:1993;1945-1951.
69. Magoffin D. Evidence that luteinizing hormone-stimulated differentiation of purified ovarian thecal-interstitial cells is mediated by both type I and type II adenosine 3′,5′-monophosphate-dependent protein kinases. Endocrinology. 125:1989;1464-1473.
70. Matteson K., Picado-Leonard J., Chung B., Mohandas T., Miller W. Assignment of the gene for adrenal P450c17 (17α-hydroxylase/17,20 lyase) to human chromosome 10. J. Clin. Endocrinol. Metab. 63:1986;789-791.
71. McAllister J., Kerin J., Trant J. et al. Regulation of cholesterol side-chain cleavage and 17α-hydroxylase/lyase activities in proliferating human theca interna cells in long term monolayer culture. Endocrinology. 125:1989;1959-1966.
72. McAllister J., Byrd W., Simpson E. The effects of growth factors and phorbol esters on steroid biosynthesis in isolated human theca interna and granulosa-lutein cells in long term culture. J. Clin. Endocrinol. Metab. 79:1994;106-112.
73. McGee E., Sawetawan C., Bird I., Rainey W., Carr B. The effect of insulin and insulin-like growth factors on the expression of steroidogenic enzymes in a human ovarian thecal-like tumor cell model. Fertil. Steril. 65:1996;87-93.
74. Mesiano S., Katz S., Lee J., Jaffe R. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J. Clin. Endocrinol. Metab. 82:1997;1390-1396.
75. Miller W. Molecular biology of steroid hormone synthesis. Endocr. Rev. 9:1988;29.
76. Moghetti P., Castello R., Negri C. et al. Insulin infusion amplifies 17α-hydroxycorticosteroid intermediates response to ACTH in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J. Clin. Endocrinol. Metab. 81:1996;881-886.
77. Morishima A., Grumbach M., Simpson E., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80:1995;3689-3698.
78. Nakajin S., Shively J., Yuan P., Hall P. Microsomal cytochrome P450 from neonatal pig testis: two enzymatic activities (17α-hydroxylase and C17,20-lyase) associated with one protein. Biochemistry. 20:1981;4037-4042.
79. Nakajin S., Hall P., Onoda M. Microsomal cytochrome P450 from neonatal pig testis; purification and properties of a C21 steroid side-chian cleavage system (17α-hydroxylase-17,21 lyase). J. Biol. Chem. 256:1981;3871-3876.
80. Nakajin S., Shinoda M., Hall P. Purification and properties of 17α-hydroxylase from microsomes of pig adrenal: a second C21 side-chain cleavage system. Biochem. Biophys. Res. Commun. 111:1983;512-517.
81. Nestler J., Jakubowicz D. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in women with polycystic ovary syndrome. New Engl. J. Med. 335:1996;617-623.
82. Nestler J., Jakubowicz D. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α activity and serum androgens. J. Clin. Endocrinol. Metab. 82:1997;4075-4079.
83. Nestler J.E., Barlascini C.O., Matt D.W. et al. Suppression of serum insulin levels by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 68:1989;1027-1032.
84. Nestler J., Powers L., Matt D. et al. A direct effect of hyperinsulinemia on serum sex-hormone binding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 72:1991;83-89.
85. Ono H., Iwasaki M., Sakamoto N., Misuno S. cDNA cloning and sequcece analysis of a chicken gene expressed during the gonadal development and homologous to mammalian cytochrome P-450c17. Gene. 66:1988;77-85.
86. Pang S. Congenital adrenal hyperplasia. Bailliéres Clin. Obstet. Gynaecol. 11(2):1997;281.
87. Picado-Leonard J., Miller W. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA. 6:1987;439-448.
88. Prelevic G., Wurzburger M., Balint-Peri cL., Nesic J. Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet. 336:1990;900-903.
89. Rheaume E., Lachance Y., Zhao H. et al. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase in human adrenals and gonads. Mol. Endocrinol. 5:1991;1147-1157.
90. Robinson S., Kiddy D., Gelding S. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol. 39:1993;351-355.
91. Rodriguez H., Hum D., Staels B., Miller W. Transcription of the human genes for cytochrome P450scc and P450c17 is regulated differently in human adrenal NCI-H295 cells than in mouse adrenal Y1 cells. J. Clin. Endocrinol. Metab. 82:1997;365-371.
92. Rosenfield, R., Ehrmann, D., Barnes, R., Brigell, D., Chandler, D., 1992. Ovarian steroidogenic abnormalities in polycystic ovary syndrome: evidence for abnormal coordinate regulation of androgen and estrogen secretion. In: Dunaif, A., Givens, J., Haseltine, F., Merriam, G. (Eds.), Polycystic Ovary Syndrome. Blackwell Scientific Publications, Cambridge, MA, pp. 83-110.
93. Rosenfield R.L., Barnes R.B., Cara J.F., Lucky A.W. Dysregulation of cytochrome P450c17α as the cause of polycystic ovary syndrome. Fertil. Steril. 53:1990;785-791.
94. Rosenfield R.L., Barnes R.B., Ehrmann D.A. Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin releasing hormone agonist challenge in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 79:1994;1686-1692.
95. Rosenfield R.L. Editorial: evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved. J. Clin. Endocrinol. Metab. 81(3):1996;878-880.
96. Rosenfield R. Current concepts of polycystic ovary syndrome. Baillières Clin. Obstet. Gynaecol. 11:1997;307-333.
97. Ryan K., Smith O. Biogenesis of steroid hormones in the human ovary. Rec. Prog. Horm. Res. 21:1965;367-409.
98. Sakai N., Tanaka M., Adachi S., Miller W., Nagahama Y. Rainbow trout cytodhrome P-450c17 (17α-hydroxylase/17,20-lyase): cDNA cloning, enzymatic properties and temporal pattern of ovarian P450c17 mRNA expression during oogenesis. FEBS Lett. 301:1992;60-64.
99. Sanchez R., Rheaume E., LaFlamme N., Simard J., Rosenfield R., Labrie F. Detection and functional characterization of the novel missense mutation Y254D in type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene of a female patient with nonsalt-losing 3β-HSD deficiency. J. Clin. Endocrinol. Metab. 78:1994;561-567.
100. Sasano H., Okamoto M., Mason J. et al. Immunolocalization of aromatase, 17α-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J. Reprod. Fert. 85:1989;163-169.
101. Sawetawan C., Carr B., McGee E., Birb I., Hong T., Rainey W. Inhibin and activin differentially regulate androgen production and 17α-hydroxylase ecpression in human ovarian thecal-like tumor cells. J. Endocrinol. 148:1996;213-221.
102. Shozu M., Akasofu K., Harada T., Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J. Clin. Endocrinol. Metab. 72:1991;560-566.
103. Sparkes R., Klisak I., Miller W. Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. DNA Cell. Biol. 10:1991;359-365.
104. Stocco D., Clark B. Regulation of the acute production of steroids in steroidogenic cells. Endocr. Rev. 17:1996;221-244.
105. Takayama K., Fukaya T., Sasano H. et al. Immunohistochemical study of steroidogenesis and cell proliferation in polucystic ovarian syndrome. Hum. Reprod. 11:1996;1387-1392.
106. Techatraisak K., Conway G., Rumsby G. Frequency of a polymorphism in the regulatory region of the 17α-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states. Clin. Endocrinol. 46:1997;131-134.
107. Trant J. Isolation and characterization of the cDNA encoding the spiny dogfish shark (Squalus acanthias) form of cytochrome P450c17. J. Exp. Zoo. 272:1995;25-33.
108. Trembkay Y., Fleury A., Beaudoin C., Valle M., Belanger A. Molecular cloning and expression of guinea pig cytochrome P450c17 cDNA (steroid 17-alpha-hydroxylase 17,20 lyase)-tissue distribution, regulation, and substrate specificity of the expressed enzyme. DNA Cell. Biol. 13:1994;1199-1212.
109. Voutilainen R., Tapanainen J., Chung B., Matteson K., Miller W. Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17α-hydroxylase/17,20-lyase) in cultured human granulosa cells. J. Clin. Endocrinol. Metab. 63:1986;202.
110. Waterman M. Biochemical diversity of cAMP-dependent transcription of steroid hydroxylase genes in the adrenal cortex. J. Biol. Chem. 269:1994;27783-27786.
111. Wrathall J., Knight P. Effects of inhibin-related peptides and oestradiol on androstenedione and progesterone secretion by bovine theca cells in vitro. J. Endocrinol. 145:1995;491-500.
112. Yanase T., Kagimoto M., Suzuki S., Hashiba K., Simpson E., Waterman M. Deletion of a phenylalanine in the N-terminal region of human cytochrome P-450(17 alpha) results in partial combined 17 alpha-hydroxylase/17,20-lyase deficiency. J. Biol. Chem. 264:1989;18076-18082.
113. Yanase T., Sanders D., Shibata A., Matsui N., Simpson E., Waterman M. Combined 17α-hydroxylase/17,20-lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochrome P450c17α (CYP17) gene. J. Clin. Endocrinol. Metab. 70:1990;1325-1329.
114. Yanase T. 17α-hydroxylase/17,20-lyase defects. J. Steroid. Biochem. Mol. Biol. 53:1995;153-157.
115. Zuber M., John M., Okamura T., Simpson E., Waterman M. Bovine adrenal cytochrome P45017: regulation of gene expression by ACTH and eludication of primary sequence. J. Biol. Chem. 261:1986;2475-2482.
116. Zuber M., Simpson E., Waterman M. Expression of bovine 17α-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science. 234:1986;1258-1261.